Yes, collaboration between industry and academia is increasingly common and beneficial. Pharmaceutical companies bring expertise in drug development and commercialization, while academic institutions contribute cutting-edge research and clinical insights. Partnerships such as those seen in the Cancer Moonshot initiative exemplify how joint efforts can lead to significant advancements.
